An hA3A mutant bearing a defective cytidine deaminase active site remains able to inhibit IAP retrotransposition

An hA3A mutant bearing a defective cytidine deaminase active site remains able to inhibit IAP retrotransposition

Copyright information:Taken from "APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells"Nucleic Acids Research 2006;34(1):89-95.Published online 10 Jan 2006PMCID:PMC1326241.© The Author 2006. Published by Oxford University Press. All rights reserved The...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bogerd, Hal P., Wiegand, Heather L., Doehle, Brian P., Lueders, Kira K., Cullen, Bryan R.
Format: Bild
Sprache:eng
Schlagworte:
FOS: Biological sciences
Genetics
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Bogerd, Hal P.
Wiegand, Heather L.
Doehle, Brian P.
Lueders, Kira K.
Cullen, Bryan R.
description Copyright information:Taken from "APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells"Nucleic Acids Research 2006;34(1):89-95.Published online 10 Jan 2006PMCID:PMC1326241.© The Author 2006. Published by Oxford University Press. All rights reserved These data were derived and are presented as described in and again used a primary antibody specific for the HA epitope tag, present on both the β-arrestin and hA3A proteins, in the lower panel. The hA3A (SPC-AAA) mutant bears alanine residues in place of the active site residues 99-SPC-101.
doi_str_mv 10.6084/m9.figshare.37951
format Image
fullrecord <record><control><sourceid>datacite_PQ8</sourceid><recordid>TN_cdi_datacite_primary_10_6084_m9_figshare_37951</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_6084_m9_figshare_37951</sourcerecordid><originalsourceid>FETCH-datacite_primary_10_6084_m9_figshare_379513</originalsourceid><addsrcrecordid>eNqdjjsOgkAQhrexMOoB7OYCIgRflMRotLOw3wwwyCTuQHZHE28vvi5g9Sf_K58x0ySOVvFmMXdZVPMlNOgpStfZMhmaLhdo8jQHd1MUhYLQs1wAoaKaSuU7QflQrliot9CxYCDATxJYCTw5ZAmAxZVAW2BpuGCFY37qM_WtepTQtX2ZWxmbQY3XQJOvjkyy3523h1mFimX_ZzvPDv3DJrF9UVuX2R-1fVOn_2yeDbJWWg</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>image</recordtype></control><display><type>image</type><title>An hA3A mutant bearing a defective cytidine deaminase active site remains able to inhibit IAP retrotransposition</title><source>DataCite</source><creator>Bogerd, Hal P. ; Wiegand, Heather L. ; Doehle, Brian P. ; Lueders, Kira K. ; Cullen, Bryan R.</creator><creatorcontrib>Bogerd, Hal P. ; Wiegand, Heather L. ; Doehle, Brian P. ; Lueders, Kira K. ; Cullen, Bryan R.</creatorcontrib><description>Copyright information:Taken from "APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells"Nucleic Acids Research 2006;34(1):89-95.Published online 10 Jan 2006PMCID:PMC1326241.© The Author 2006. Published by Oxford University Press. All rights reserved These data were derived and are presented as described in and again used a primary antibody specific for the HA epitope tag, present on both the β-arrestin and hA3A proteins, in the lower panel. The hA3A (SPC-AAA) mutant bears alanine residues in place of the active site residues 99-SPC-101.</description><identifier>DOI: 10.6084/m9.figshare.37951</identifier><language>eng</language><publisher>figshare</publisher><subject>FOS: Biological sciences ; Genetics</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>780,1894</link.rule.ids><linktorsrc>$$Uhttps://commons.datacite.org/doi.org/10.6084/m9.figshare.37951$$EView_record_in_DataCite.org$$FView_record_in_$$GDataCite.org$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Bogerd, Hal P.</creatorcontrib><creatorcontrib>Wiegand, Heather L.</creatorcontrib><creatorcontrib>Doehle, Brian P.</creatorcontrib><creatorcontrib>Lueders, Kira K.</creatorcontrib><creatorcontrib>Cullen, Bryan R.</creatorcontrib><title>An hA3A mutant bearing a defective cytidine deaminase active site remains able to inhibit IAP retrotransposition</title><description>Copyright information:Taken from "APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells"Nucleic Acids Research 2006;34(1):89-95.Published online 10 Jan 2006PMCID:PMC1326241.© The Author 2006. Published by Oxford University Press. All rights reserved These data were derived and are presented as described in and again used a primary antibody specific for the HA epitope tag, present on both the β-arrestin and hA3A proteins, in the lower panel. The hA3A (SPC-AAA) mutant bears alanine residues in place of the active site residues 99-SPC-101.</description><subject>FOS: Biological sciences</subject><subject>Genetics</subject><fulltext>true</fulltext><rsrctype>image</rsrctype><creationdate>2011</creationdate><recordtype>image</recordtype><sourceid>PQ8</sourceid><recordid>eNqdjjsOgkAQhrexMOoB7OYCIgRflMRotLOw3wwwyCTuQHZHE28vvi5g9Sf_K58x0ySOVvFmMXdZVPMlNOgpStfZMhmaLhdo8jQHd1MUhYLQs1wAoaKaSuU7QflQrliot9CxYCDATxJYCTw5ZAmAxZVAW2BpuGCFY37qM_WtepTQtX2ZWxmbQY3XQJOvjkyy3523h1mFimX_ZzvPDv3DJrF9UVuX2R-1fVOn_2yeDbJWWg</recordid><startdate>20111231</startdate><enddate>20111231</enddate><creator>Bogerd, Hal P.</creator><creator>Wiegand, Heather L.</creator><creator>Doehle, Brian P.</creator><creator>Lueders, Kira K.</creator><creator>Cullen, Bryan R.</creator><general>figshare</general><scope>DYCCY</scope><scope>PQ8</scope></search><sort><creationdate>20111231</creationdate><title>An hA3A mutant bearing a defective cytidine deaminase active site remains able to inhibit IAP retrotransposition</title><author>Bogerd, Hal P. ; Wiegand, Heather L. ; Doehle, Brian P. ; Lueders, Kira K. ; Cullen, Bryan R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-datacite_primary_10_6084_m9_figshare_379513</frbrgroupid><rsrctype>images</rsrctype><prefilter>images</prefilter><language>eng</language><creationdate>2011</creationdate><topic>FOS: Biological sciences</topic><topic>Genetics</topic><toplevel>online_resources</toplevel><creatorcontrib>Bogerd, Hal P.</creatorcontrib><creatorcontrib>Wiegand, Heather L.</creatorcontrib><creatorcontrib>Doehle, Brian P.</creatorcontrib><creatorcontrib>Lueders, Kira K.</creatorcontrib><creatorcontrib>Cullen, Bryan R.</creatorcontrib><collection>DataCite (Open Access)</collection><collection>DataCite</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Bogerd, Hal P.</au><au>Wiegand, Heather L.</au><au>Doehle, Brian P.</au><au>Lueders, Kira K.</au><au>Cullen, Bryan R.</au><format>book</format><genre>unknown</genre><ristype>GEN</ristype><title>An hA3A mutant bearing a defective cytidine deaminase active site remains able to inhibit IAP retrotransposition</title><date>2011-12-31</date><risdate>2011</risdate><abstract>Copyright information:Taken from "APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells"Nucleic Acids Research 2006;34(1):89-95.Published online 10 Jan 2006PMCID:PMC1326241.© The Author 2006. Published by Oxford University Press. All rights reserved These data were derived and are presented as described in and again used a primary antibody specific for the HA epitope tag, present on both the β-arrestin and hA3A proteins, in the lower panel. The hA3A (SPC-AAA) mutant bears alanine residues in place of the active site residues 99-SPC-101.</abstract><pub>figshare</pub><doi>10.6084/m9.figshare.37951</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier DOI: 10.6084/m9.figshare.37951
ispartof
issn
language eng
recordid cdi_datacite_primary_10_6084_m9_figshare_37951
source DataCite
subjects FOS: Biological sciences
Genetics
title An hA3A mutant bearing a defective cytidine deaminase active site remains able to inhibit IAP retrotransposition
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T17%3A55%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-datacite_PQ8&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.au=Bogerd,%20Hal%20P.&rft.date=2011-12-31&rft_id=info:doi/10.6084/m9.figshare.37951&rft_dat=%3Cdatacite_PQ8%3E10_6084_m9_figshare_37951%3C/datacite_PQ8%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true